Biotech

All Articles

Merck's LAG-3 combo stops working intestines cancer cells phase 3 study

.A try through Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic intestines cancer...

Spanish VC closes $200M lifestyle scientific researches fund

.Spain-based Asabys Partners has actually closed a fund of 180 thousand europeans ($ 200 million), l...

BioAge produces $198M coming from IPO as weight problems biotech joins Nasdaq

.BioAge Labs is generating practically $200 million by means of its Nasdaq IPO today, along with the...

Acadia carries BMS vet aboard as CEO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also...

Cassava pays for $40M over presumably confusing Alzheimer's improve

.Cassava Sciences has actually consented to pay out $40 million to solve an investigation right into...

Merck bags alternatives on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has picked up alternatives on two Evaxion Biotech vaccination applicants, paying $3....

Enanta's RSV antiviral crushes popular bunch in challenge research study

.Enanta Pharmaceuticals has connected its respiratory system syncytial virus (RSV) antiviral to subs...

Biogen containers SAGE-324 cooperation after crucial tremor fall short

.Biogen has actually carried out the last rites to its own cooperation with Sage Therapies on SAGE-3...

AbbVie Parkinson's medication coming from $8.7 B Cerevel buyout credit ratings

.On the same day that some Parkinson's ailment drugs are being questioned, AbbVie has declared that ...

Arch finalizes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund from Bain Funds Lifestyle Sciences, Arch Project Partners is actu...